Bronchoscopic lung volume reduction coil treatment of patients with severe heterogeneous emphysema

Chest

Volumn 142, Issue 3, 2012, Pages 574-582

  Slebos, Dirk Jan ^a   Klooster, Karin ^a   Ernst, Armin ^b   Herth, Felix J F ^c   Kerstjens, Huib A M ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Pneumology and Critical Care Medicine   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

NITINOL;

ADULT; ARTICLE; BRONCHOSCOPY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; DEVICE SAFETY; DISEASE EXACERBATION; DISEASE SEVERITY; EXERCISE TEST; FEMALE; FLUOROSCOPY; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HEMOPTYSIS; HUMAN; LUNG EMPHYSEMA; LUNG FUNCTION TEST; LUNG RESECTION; LUNG VOLUME REDUCTION COIL; MALE; PNEUMONIA; PNEUMOTHORAX; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; QUESTIONNAIRE; RESIDUAL VOLUME; SEVERE HETEROGENEOUS EMPHYSEMA; SURGICAL EQUIPMENT; SURGICAL TECHNIQUE; THORAX PAIN; TREATMENT RESPONSE;

EID: 84865847726     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.11-0730     Document Type: Article

References (37)

1. Rabe KF, Hurd S, Anzueto A, et alGlobal Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007;176(6):532-555. (Pubitemid 47403272)
2. O'Donnell DE, Webb KA. The major limitation to exercise performance in COPD is dynamic hyperinflation. J Appl Physiol. 2008;105(2):753-755.
3. Casanova C, Cote C, de Torres JP, et al. Inspiratory-to-total lung capacity ratio predicts mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2005;171(6):591-597. (Pubitemid 40365414)
4. Martinez FJ, Chang A. Surgical therapy for chronic obstructive pulmonary disease. Semin Respir Crit Care Med. 2005;26(2):167-191. (Pubitemid 40617295)
5. Fishman A, Martinez F, Naunheim K, et al National Emphysema Treatment Trial Research Group. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med. 2003;348 (21):2059-2073. (Pubitemid 36583301)
6. Hosenpud JD, Bennett LE, Keck BM, Edwards EB, Novick RJ. Effect of diagnosis on survival benefit of lung transplan tation for end-stage lung disease. Lancet. 1998;351(9095):24-27. (Pubitemid 28020162)
7. Hopkinson NS, Toma TP, Hansell DM, et al. Effect of bronchoscopic lung volume reduction on dynamic hyperinflation and exercise in emphysema. Am J Respir Crit Care Med. 2005;171(5):453-460. (Pubitemid 40444245)
8. Wood DE, McKenna RJ Jr, Yusen RD, et al. A multicenter trial of an intrabronchial valve for treatment of severe emphysema. J Thorac Cardiovasc Surg. 2007;133(1):65-73.
9. Sciurba FC, Ernst A, Herth FJ, et alVENT Study Research Group. A randomized study of endobronchial valves for advanced emphysema. N Engl J Med. 2010;363 (13):1233- 1244.
10. Gompelmann D, Eberhardt R, Michaud G, Ernst A, Herth FJ. Predicting atelectasis by assessment of collateral ventilation prior to endobronchial lung volume reduction: a feasibility study. Respiration. 2010;80(5):419-425.
11. Herth FJ, Eberhard R, Gompelmann D, Slebos DJ, Ernst A. Bronchoscopic lung volume reduction with a dedicated coil: a clinical pilot study. Ther Adv Respir Dis 2010;4(4)225-231.
12. American Thoracic Society. Surveillance for respiratory hazards in the occupational setting. Am Rev Respir Dis. 1982;126(5):952-956.
13. Stoel BC, Bode F, Rames A, Soliman S, Reiber JH, Stolk J. Quality control in longitudinal studies with computed tomographic densitometry of the lungs. Proc Am Thorac Soc. 2008;5(9):929-933.
14. Stolk J, Versteegh MI, Montenij LJ, et al. Densitometry for assessment of effect of lung volume reduction surgery for emphysema. Eur Respir J. 2007;29(6):1138-1143. (Pubitemid 46895372)
15. Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. Am Rev Respir Dis. 1992;145(6):1321-1327.
16. Miller MR, Crapo R, Hankinson J, et al ATS/ERS Task Force. General considerations for lung function testing. Eur Respir J. 2005;26(1):153-161. (Pubitemid 40945944)
17. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002;166(1):111-117.
18. NOMENCLATURE of broncho-pulmonary anatomy; an international nomenclature accepted by the Thoracic Soci ety. Thorax. 1950;5(3):222-228.
19. Donohue JF. Minimal clinically important differences in COPD lung function. COPD. 2005;2(1):111-124. (Pubitemid 40776231)
20. Wise RA, Brown CD. Minimal clinically important differences in the six-minute walk test and the incremental shuttle walking test. COPD. 2005;2(1):125-129. (Pubitemid 40776232)
21. Puhan MA, Chandra D, Mosenifar Z, et al National Emphysema Treatment Trial (NETT) Research Group. The minimal important difference of exercise tests in severe COPD. Eur Respir J. 2011;37(4):784-790.
22. Holland AE, Hill CJ, Rasekaba T, Lee A, Naughton MT, McDonald CF. Updating the minimal important difference for six-minute walk distance in patients with chronic obstruc tive pulmonary disease. Arch Phys Med Rehabil. 2010;91(2):221-225.
23. Jones PW. St. George's Respiratory Questionnaire: MCID. COPD. 2005;2(1):75-79.
24. Sterman DH, Mehta AC, Wood DE, et al IBV Valve US Pilot Trial Research Team. A multicenter pilot study of a bronchial valve for the treatment of severe emphysema. Respiration. 2010;79(3):222-233.
25. Springmeyer SC, Bolliger CT, Waddell TK, Gonzalez X, Wood DE;IBV Valve Pilot Trials Research Teams. Treatment of heterogeneous emphysema using the spiration IBV valves. Thorac Surg Clin. 2009;19(2):247-253.
26. Snell GI, Hopkins P, Westall G, Holsworth L, Carle A, Williams TJ. A feasibility and safety study of bronchoscopic thermal vapor ablation: a novel emphysema therapy. Ann Thorac Surg. 2009;88(6):1993-1998.
27. Wan IY, Toma TP, Geddes DM, et al. Bronchoscopic lung volume reduction for end-stage emphysema: report on the first 98 patients. Chest. 2006;129(3):518-526.
28. Cardoso PF, Snell GI, Hopkins P, et al. Clinical application of airway bypass with paclitaxel-eluting stents: early results. J Thorac Cardiovasc Surg. 2007;134(4):974-981. (Pubitemid 47454624)
29. Venuta F, de Giacomo T, Rendina EA, et al. Bronchoscopic lung-volume reduction with one-way valves in patients with heterogenous emphysema. Ann Thorac Surg. 2005;79 (2):411- 416.
30. Yim AP, Hwong TM, Lee TW, et al. Early results of endoscopic lung volume reduction for emphysema. J Thorac Cardiovasc Surg. 2004;127(6):1564-1573. (Pubitemid 38725432)
31. Edrich T, Sadovnikoff N. Anesthesia for patients with severe chronic obstructive pulmonary disease. Curr Opin Anaesthesiol. 2010;23(1):18-24.
32. Cooper CB. The connection between chronic obstructive pulmonary disease symptoms and hyperinflation and its impact on exercise and function. Am J Med. 2006;119 (10)(s uppl 1):21- 31.
33. Sciurba FC, Rogers RM, Keenan RJ, et al. Improvement in pulmonary function and elastic recoil after lung-reduction surgery for diffuse emphysema. N Engl J Med. 1996;334 (17):1095-1099. (Pubitemid 26120187)
34. Shabalovskaya SA. Surface, corrosion and biocompatibility aspects of Nitinol as an implant material. Biomed Mater Eng. 2002;12(1):69-109. (Pubitemid 34177344)
35. Duerig TW, Pelton AR, Stöckel D. The utility of superelasticity in medicine. Biomed Mater Eng. 1996;6(4):255-266. (Pubitemid 126443033)
36. Fessler HE. Collateral ventilation, the bane of bronchoscopic volume reduction. Am J Respir Crit Care Med. 2005;171(5):423-424. (Pubitemid 40444239)
37. Hogg JC, Macklem PT, Thurlbeck WM. The resistance of collateral channels in excised human lungs. J Clin Invest. 1969;48(3):421-431.